← All trials
NCT02893124
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Aug 1, 2017
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Sun Yat-Sen UniversityLead sponsor
- People's Liberation Army of ChinaCollaborator
- Sun Yat-Sen UniversityReponsible party - principal investigator
- Peking UniversityCollaborator
- Nanchang UniversityCollaborator
- Shenzhen Third People's HospitalCollaborator
- First People's Hospital of FoshanCollaborator
- First People's Hospital, Shunde ChinaCollaborator
- Yuebei People's HospitalCollaborator
- Kunming Medical UniversityCollaborator
- Huizhou People's Central HospitalCollaborator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.